-
1
-
-
77952339902
-
Slow elimination of multidrug-resistant tuberculosis
-
3ra8
-
Dye C, Williams BG. Slow elimination of multidrug-resistant tuberculosis. Sci Transl Med 2009; 1: 3ra8.
-
(2009)
Sci Transl Med
, vol.1
-
-
Dye, C.1
Williams, B.G.2
-
2
-
-
1642537638
-
Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosis
-
Nuermberger EL, Yoshimatsu T, Tyagi S et al. Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosis. Am J Respir Crit Care Med 2004; 169: 421-6.
-
(2004)
Am J Respir Crit Care Med
, vol.169
, pp. 421-426
-
-
Nuermberger, E.L.1
Yoshimatsu, T.2
Tyagi, S.3
-
3
-
-
63349091494
-
Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial
-
Conde MB, Efron A, Loredo C et al. Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial. Lancet 2009; 373: 1183-9.
-
(2009)
Lancet
, vol.373
, pp. 1183-1189
-
-
Conde, M.B.1
Efron, A.2
Loredo, C.3
-
4
-
-
67650046677
-
Delineating bacteriostatic and bactericidal targets in mycobacteria using IPTG inducible antisense expression
-
Kaur P, Agarwal S, Datta S. Delineating bacteriostatic and bactericidal targets in mycobacteria using IPTG inducible antisense expression. PLoS One 2009; 4: e5923.
-
(2009)
PLoS One
, vol.4
-
-
Kaur, P.1
Agarwal, S.2
Datta, S.3
-
5
-
-
51849112827
-
Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationships
-
Charifson PS, Grillot A-L, Grossman TH et al. Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationships. J Med Chem 2008; 51: 5243-63.
-
(2008)
J Med Chem
, vol.51
, pp. 5243-5263
-
-
Charifson, P.S.1
Grillot, A.-L.2
Grossman, T.H.3
-
6
-
-
33846582343
-
Dual targeting of GyrB and ParE by a novel aminobenzimidazole class of antibacterial compounds
-
Grossman TH, Bartels DJ, Mullin S et al. Dual targeting of GyrB and ParE by a novel aminobenzimidazole class of antibacterial compounds. Antimicrob Agents Chemother 2007; 51: 657-66.
-
(2007)
Antimicrob Agents Chemother
, vol.51
, pp. 657-666
-
-
Grossman, T.H.1
Bartels, D.J.2
Mullin, S.3
-
7
-
-
79951996244
-
A high-throughput fluorescence polarization assay for inhibitors of gyrase B
-
Glaser BT, Malerich JP, Duellman SJ et al. A high-throughput fluorescence polarization assay for inhibitors of gyrase B. J Biomol Screen 2011; 16: 230-8.
-
(2011)
J Biomol Screen
, vol.16
, pp. 230-238
-
-
Glaser, B.T.1
Malerich, J.P.2
Duellman, S.J.3
-
8
-
-
34547112538
-
Mycobacterium tuberculosis DNA gyrase as a target for drug discovery
-
Mdluli K, Ma Z. Mycobacterium tuberculosis DNA gyrase as a target for drug discovery. Infect Disord Drug Targets 2007; 7: 159-68.
-
(2007)
Infect Disord Drug Targets
, vol.7
, pp. 159-168
-
-
Mdluli, K.1
Ma, Z.2
-
9
-
-
0030903133
-
Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium
-
Collins L, Franzblau SG. Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob Agents Chemother 1997; 41: 1004-9.
-
(1997)
Antimicrob Agents Chemother
, vol.41
, pp. 1004-1009
-
-
Collins, L.1
Franzblau, S.G.2
-
10
-
-
0000753290
-
Antimicrobial susceptibility testing
-
Henry DI, ed. Washington, DC: American Society for Microbiology
-
Hindler J. Antimicrobial susceptibility testing. In: Henry DI, ed. Clinical Microbiology Procedures Handbook. Washington, DC: American Society for Microbiology, 1992.
-
(1992)
Clinical Microbiology Procedures Handbook
-
-
Hindler, J.1
-
11
-
-
0038601510
-
Synergy, antagonism, and what the chequerboard puts between them
-
Odds FC. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 2003; 52: 1.
-
(2003)
J Antimicrob Chemother
, vol.52
, pp. 1
-
-
Odds, F.C.1
-
12
-
-
34247143197
-
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis
-
Cho SH, Warit S, Wan B et al. Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis. Antimicrob Agents Chemother 2007; 51: 1380-5.
-
(2007)
Antimicrob Agents Chemother
, vol.51
, pp. 1380-1385
-
-
Cho, S.H.1
Warit, S.2
Wan, B.3
-
13
-
-
84855835041
-
Isolation of DNA from Mycobacterium tuberculosis
-
Parish T, Stoker NG, eds. New York: Humana Press
-
Van Helden PD, Victor TC, Warren RM et al. Isolation of DNA from Mycobacterium tuberculosis. In: Parish T, Stoker NG, eds. Mycobacterium tuberculosis protocols. New York: Humana Press, 2001; 19-30.
-
(2001)
Mycobacterium tuberculosis protocols
, pp. 19-30
-
-
Van Helden, P.D.1
Victor, T.C.2
Warren, R.M.3
-
14
-
-
0023792919
-
Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines
-
Scudiero DA, Shoemaker RH, Paull KD et al. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 1988; 48: 4827-33.
-
(1988)
Cancer Res
, vol.48
, pp. 4827-4833
-
-
Scudiero, D.A.1
Shoemaker, R.H.2
Paull, K.D.3
-
15
-
-
0031105464
-
DNA gyrase as a drug target
-
Maxwell A. DNA gyrase as a drug target. Trends Microbiol 1997; 5: 102-9.
-
(1997)
Trends Microbiol
, vol.5
, pp. 102-109
-
-
Maxwell, A.1
-
16
-
-
77957908236
-
Structural insights into the quinolone resistance mechanism of Mycobacterium tuberculosis DNA gyrase
-
Piton J, Petrella S, Delarue M et al. Structural insights into the quinolone resistance mechanism of Mycobacterium tuberculosis DNA gyrase. PLoS One 2010; 5: e12245.
-
(2010)
PLoS One
, vol.5
-
-
Piton, J.1
Petrella, S.2
Delarue, M.3
-
17
-
-
0035940515
-
Comprehensive identification of conditionally essential genes in mycobacteria
-
Sassetti CM, Boyd DH, Rubin EJ. Comprehensive identification of conditionally essential genes in mycobacteria. Proc Natl Acad Sci USA 2001; 98: 12712-7.
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, pp. 12712-12717
-
-
Sassetti, C.M.1
Boyd, D.H.2
Rubin, E.J.3
-
18
-
-
0032504252
-
Topoisomerase IV catalysis and the mechanism of quinolone action
-
Anderson VE, Gootz TD, Osheroff N. Topoisomerase IV catalysis and the mechanism of quinolone action. J Biol Chem 1998; 273: 17879-85.
-
(1998)
J Biol Chem
, vol.273
, pp. 17879-17885
-
-
Anderson, V.E.1
Gootz, T.D.2
Osheroff, N.3
-
19
-
-
58149182735
-
TB database: an integrated platform for tuberculosis research
-
Reddy TB, Riley R, Wymore F et al. TB database: an integrated platform for tuberculosis research. Nucleic Acids Res 2009; 37: D499-508.
-
(2009)
Nucleic Acids Res
, vol.37
-
-
Reddy, T.B.1
Riley, R.2
Wymore, F.3
-
20
-
-
0037311481
-
Sterilizing activities of fluoroquinolones against rifampin-tolerant populations of Mycobacterium tuberculosis
-
Hu Y, Coates AR, Mitchison DA. Sterilizing activities of fluoroquinolones against rifampin-tolerant populations of Mycobacterium tuberculosis. Antimicrob Agents Chemother 2003; 47: 653-7.
-
(2003)
Antimicrob Agents Chemother
, vol.47
, pp. 653-657
-
-
Hu, Y.1
Coates, A.R.2
Mitchison, D.A.3
|